PNDUS BIOTECHNOLOGY is a Shenzhen-based startup that specializes in the design and manufacture of disposable E-Cigs, advanced E-Cig Atomizers, E-Cig Accessories, and Medical Nebulizers. Established in 2020, the company operates in the Greater Bay Area of Guangdong, Hong Kong, and Macao, known as the world's electronic cigarette capital and often referred to as the "Oriental Silicon Valley."
The company's focus lies in the development, manufacturing, and sale of atomizer equipment, electronic cigarettes, accessories, medical equipment, health care products, and biotechnology. With a commitment to cutting-edge design concepts and patented technology, PNDUS BIOTECHNOLOGY invests significantly in research and development, emphasizing innovation and product development with customer needs at the forefront.
Operating from a new garden-style factory with a medical-grade workshop spanning 25,000 square meters, the company boasts a workforce of 1,300 personnel and an annual output value of approximately RMB 1.2 billion. The company prioritizes a pragmatic and down-to-earth business philosophy, striving for sustainable growth.
The corporate culture and philosophy center around a commitment to providing superior quality devices through innovative technology and custom designs, with a clear mission to protect people’s health. Their vision emphasizes pioneering quality in the electronics industry, delivering products that make a substantial difference in people’s lives.
As a manufacturing and retail company, PNDUS BIOTECHNOLOGY also offers OEM/ODM services, demonstrating a comprehensive approach to meeting the diverse needs of the market.
There is no investment information
No recent news or press coverage available for PNDUS BIOTECHNOLOGY.